These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32820807)

  • 41. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
    Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022.
    Hatfield KM; Baggs J; Maillis A; Warner S; Jernigan JA; Kadri SS; Klompas M; Reddy SC
    JAMA Netw Open; 2023 Aug; 6(8):e2329441. PubMed ID: 37639273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
    J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
    Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
    Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
    Bolker A; Coe K; Smith J; Stevenson K; Wang SH; Reed E
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115558. PubMed ID: 34731685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020.
    Puzniak L; Bauer KA; Yu KC; Moise P; Finelli L; Ye G; De Anda C; Vankeepuram L; Gupta V
    Open Forum Infect Dis; 2021 Jun; 8(6):ofab232. PubMed ID: 34141818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association Between Early Antibiotic Therapy and In-Hospital Mortality Among Older Patients With SARS-CoV-2 Pneumonia.
    Putot A; Bouiller K; Laborde C; Gilis M; Fèvre A; Hacquin A; Manckoundia P; Hoefler F; Bermejo M; Mendes A; Serratrice C; Prendki V; Sanchez S
    J Gerontol A Biol Sci Med Sci; 2022 Apr; 77(4):e115-e123. PubMed ID: 34272847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of bacterial coinfections and susceptible antibiotic profiles in hospitalized COVID-19 patients in Koya district, Iraq.
    Omar SZ; Mustafa SK
    J Infect Dev Ctries; 2023 Nov; 17(11):1537-1543. PubMed ID: 38064399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study.
    Sierra-Hidalgo F; Aragón Revilla E; Arranz García P; Martínez-Acebes E; Gómez-Moreno SM; Muñoz-Rivas N; Esquivel López A;
    Neurocrit Care; 2022 Feb; 36(1):208-215. PubMed ID: 34268645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT).
    Johnson MG; Strizki JM; Jensen E; Cohen J; Katlama C; Fishchuk R; Ponce-de-León A; Fourie N; Cheng C-Y; McCoy D; Vesnesky M; Norice CT; Zhang Y; Williams-Diaz A; Brown ML; Carmelitano P; Grobler JA; Paschke A; De Anda C
    Microbiol Spectr; 2024 Mar; 12(3):e0356323. PubMed ID: 38299867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study.
    Bhatt PJ; Shiau S; Brunetti L; Xie Y; Solanki K; Khalid S; Mohayya S; Au PH; Pham C; Uprety P; Nahass R; Narayanan N
    Clin Infect Dis; 2021 Jun; 72(12):e995-e1003. PubMed ID: 33216875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system.
    Lardaro T; Wang AZ; Bucca A; Croft A; Glober N; Holt DB; Musey PI; Peterson KD; Trigonis RA; Schaffer JT; Hunter BR
    J Med Virol; 2021 May; 93(5):2883-2889. PubMed ID: 33448423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study.
    Tiseo G; Suardi LR; Giusti L; Forniti A; Caroselli C; Galfo V; Occhineri S; Leonildi A; Moscato G; Menichetti F; Falcone M
    Respirology; 2022 Nov; 27(11):987-990. PubMed ID: 36113869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and risk factors associated with multidrug-resistant bacteria in COVID-19 patients.
    Aldarhami A; Punjabi AA; Bazaid AS; Binsaleh NK; Althomali OW; Sherwani S; Hafiz O; Almishaal AA
    Medicine (Baltimore); 2024 Mar; 103(10):e37389. PubMed ID: 38457584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.
    Satyanarayana G; Enriquez KT; Sun T; Klein EJ; Abidi M; Advani SM; Awosika J; Bakouny Z; Bashir B; Berg S; Bernardes M; Egan PC; Elkrief A; Feldman LE; Friese CR; Goel S; Gomez CG; Grant KL; Griffiths EA; Gulati S; Gupta S; Hwang C; Jain J; Jani C; Kaltsas A; Kasi A; Khan H; Knox N; Koshkin VS; Kwon DH; Labaki C; Lyman GH; McKay RR; McNair C; Nagaraj G; Nakasone ES; Nguyen R; Nonato TK; Olszewski AJ; Panagiotou OA; Puc M; Razavi P; Robilotti EV; Santos-Dutra M; Schmidt AL; Shah DP; Shah SA; Vieira K; Weissmann LB; Wise-Draper TM; Wu U; Wu JT; Choueiri TK; Mishra S; Warner JL; French B; Farmakiotis D
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac037. PubMed ID: 35198648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
    Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
    J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy.
    Zilberberg M; Micek ST; Kollef MH; Shelbaya A; Shorr AF
    Surg Infect (Larchmt); 2012 Dec; 13(6):377-82. PubMed ID: 23216526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coinfections and antimicrobial treatment in a cohort of falciparum malaria in a non-endemic country: a 10-year experience.
    Küpper-Tetzel CP; Idris R; Kessel J; Schüttfort G; Hoehl S; Kohmer N; Graf C; Hogardt M; Besier S; Wichelhaus TA; Vehreschild MJGT; Stephan C; Wetzstein N
    Infection; 2024 Apr; 52(2):461-469. PubMed ID: 37889376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.